Low-Dose Interleukin-2 Altered Gut Microbiota and Ameliorated Collagen-Induced Arthritis

Na Li,1 Xuefei Li,1 Rui Su,1 Ruihe Wu,1 Hong-Qing Niu,1 Jing Luo,1 Chong Gao,2 Xiaofeng Li,1 Caihong Wang1 1Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China; 2Pathology, Joint Program in Transfusion Medicine, Brigham and W...

Full description

Saved in:
Bibliographic Details
Main Authors: Li N (Author), Li X (Author), Su R (Author), Wu R (Author), Niu HQ (Author), Luo J (Author), Gao C (Author), Wang C (Author)
Format: Book
Published: Dove Medical Press, 2022-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a9c5cee94e924ef8b23457dfcb798f60
042 |a dc 
100 1 0 |a Li N  |e author 
700 1 0 |a Li X  |e author 
700 1 0 |a Su R  |e author 
700 1 0 |a Wu R  |e author 
700 1 0 |a Niu HQ  |e author 
700 1 0 |a Luo J  |e author 
700 1 0 |a Gao C  |e author 
700 1 0 |a Li X  |e author 
700 1 0 |a Wang C  |e author 
245 0 0 |a Low-Dose Interleukin-2 Altered Gut Microbiota and Ameliorated Collagen-Induced Arthritis 
260 |b Dove Medical Press,   |c 2022-02-01T00:00:00Z. 
500 |a 1178-7031 
520 |a Na Li,1 Xuefei Li,1 Rui Su,1 Ruihe Wu,1 Hong-Qing Niu,1 Jing Luo,1 Chong Gao,2 Xiaofeng Li,1 Caihong Wang1 1Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, People's Republic of China; 2Pathology, Joint Program in Transfusion Medicine, Brigham and Women's Hospital/Children's Hospital, Harvard Medical School, Boston, MA, USACorrespondence: Caihong Wang, Tel +8613603515399, Fax +863513365551, Email snwch@sina.comPurpose: Low-dose interleukin-2 (ld-IL-2) has been shown to regulate the balance between effector T and regulatory T (Treg) cells and has been used in several clinical trials to treat autoimmune diseases including rheumatoid arthritis (RA). In this study, we investigated the effects of ld-IL-2 on collagen-induced arthritis (CIA) in mice.Methods: Arthritis severity in CIA mice was measured using the arthritis index (AI), radiographs, and hematoxylin and eosin staining. Cytokines were detected using enzyme-linked immunosorbent assay. Gut microbiota alterations and short-chain fatty acid production were analyzed through 16S rRNA sequencing and gas chromatography.Results: The AI scores of CIA mice treated with ld-IL-2 were significantly lower compared to the model group, which significantly reduced the severity of arthritis. Ld-IL-2 also altered the gut microbiota in CIA mice. The diversity, composition, and dominant species of gut microbiota were altered by ld-IL-2 treatment. Ld-IL-2 also increased short-chain fatty acid levels. There was a strong correlation between ld-IL-2 treatment and improved gut microbiota.Conclusion: Ld-IL-2 significantly ameliorated joint inflammation and bone damage and improved gut microbial dysbiosis in CIA, indicating that it may be a promising therapy for RA patients.Keywords: low-dose IL-2, CIA, gut microbiota, SCFA, 16sRNA 
546 |a EN 
690 |a low-dose il-2 
690 |a cia 
690 |a gut microbiota 
690 |a scfa 
690 |a 16srna 
690 |a Pathology 
690 |a RB1-214 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Inflammation Research, Vol Volume 15, Pp 1365-1379 (2022) 
787 0 |n https://www.dovepress.com/low-dose-interleukin-2-altered-gut-microbiota-and-ameliorated-collagen-peer-reviewed-fulltext-article-JIR 
787 0 |n https://doaj.org/toc/1178-7031 
856 4 1 |u https://doaj.org/article/a9c5cee94e924ef8b23457dfcb798f60  |z Connect to this object online.